Connection

Mark Loeb to Community-Acquired Infections

Back to Details
This is a "connection" page, showing publications Mark Loeb has written about Community-Acquired Infections.
Mark Loeb
Connection Strength
0.520
Community-Acquired Infections
  1. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial. Trials. 2018 Feb 01; 19(1):83.
    View in: PubMed
    Score: 0.289
  2. Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization? Can Fam Physician. 2019 Sep; 65(9):625-633.
    View in: PubMed
    Score: 0.081
  3. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). Vaccine. 2019 08 23; 37(36):5466-5473.
    View in: PubMed
    Score: 0.080
  4. Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open. 2017 Jul 26; 7(7):e016264.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.